Tuesday, 20 February 2018

Is Reckitt's Deal Machine Still Up to Snuff?

As the battle to buy Pfizer’s $20 billion consumer business heats up, Lysol-owner Reckitt Benckiser is trying to convince investors that its acquisition record is clean.

from WSJ.com: Markets http://ift.tt/2BCxXRA
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)